Radioiodine ablation of the thyroid to allow the reintroduction of amiodarone treatment in patients with a prior history of amiodarone-induced thyrotoxicosis.
Hermida
Jean-Sylvain
JS
Hôpital Sud (JSH), Centre Hospitalier Universitaire, Amiens, France. hermida.jean-sylvain@chu-amiens.fr
Jarry
Géneviève
G
Tcheng
Emmanuel
E
Moullart
Véronique
V
Arlot
Sylvie
S
Rey
Jean-Luc
JL
Delonca
Jean
J
Schvartz
Claire
C
D000328:Adult; D000368:Aged; D000638:Amiodarone / Q000009:adverse effects* / Q000627:therapeutic use; D000889:Anti-Arrhythmia Agents / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007457:Iodine Radioisotopes / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D012008:Recurrence; D013961:Thyroid Gland / Q000528:radiation effects; D013971:Thyrotoxicosis / Q000097:blood / Q000139:chemically induced / Q000532:radiotherapy*; D013972:Thyrotropin / Q000097:blood
D000889:Anti-Arrhythmia Agents; D007457:Iodine Radioisotopes; D013972:Thyrotropin; D000638:Amiodarone